[ad_1]
[앵커]
With Pfizer’s plan to apply for emergency approval of the Corona 19 vaccine from the United States Food and Drug Administration (FDA) today, several lawsuits, such as dry ice for storage and transportation of the vaccine, and the Cryogenic freezing facilities from -70 to 80 degrees Celsius are showing a sharp increase. . Reporter Park Cheol-won reports. When the news that the Corona 19 vaccine jointly developed by Pfizer and Bioentech of Germany plans to apply for urgent use today with the US Food and Drug Administration and the FDA, the European medical community expressed great expectations. The aviation industry, which must be transported around the world, has become very active as the vaccine becomes available for immediate distribution if the vaccine is approved for emergency use. The problem is that the Pfizer and Bioentech vaccines must be transported while maintaining cryogenic conditions. In particular, due to the nature of this vaccine, which must be stored and transported at a cryogenic temperature of -70 to 80 degrees Celsius, orders for dry ice are increasing rapidly. A German airline is doing its best to prepare for transport by urgently reviewing cryogenic refrigeration facilities, saying this is a “special challenge”. In this sense, Pfizer and Bioentech plan to transport up to 4,875 doses of vaccine in a special container. Faced with this situation, the US state government, as well as hospitals and pharmacy chains, are busy verifying dry ice production capacity and determining the order book for refrigeration facilities. Given that a serious situation continues to require all available vaccines, the cryogenic distribution of Pfizer vaccines is emerging as a pending issue for the health authorities of each country. This is YTN Park Cheolwon.
